相关实验视频

Updated: Sep 19, 2025

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

基于病理生理机制的TCM刺激性肠综合征综合治疗的探索

Xiaonan Xu¹, Yan Huang¹, Zhuolin Ma²

¹First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang Province, People's Republic of China.

International journal of general medicine

|June 18, 2025

概括

传统中国医学 (TCM) 通过解决潜在的机制,在治疗刺激性肠综合征 (IBS) 方面表现有前途. 进一步的研究可以优化TCM以改善IBS症状控制和患者的生活质量.

科学领域:

胃肠病学胃肠病学
综合医学是一个整体的医学.
药理学药理学是指药理学的学科.

背景情况:

刺激性肠综合征 (IBS) 是一种常见的胃肠疾病,其特点是腹痛和改变肠道习惯,显著影响生活质量.
目前的IBS诊断依赖于症状和排除,治疗方法包括药物,饮食和心理治疗.
肠胃综合征的病理生理学是复杂的,涉及诸如肠道透性,炎症,内脏过敏和大脑肠道相互作用的改变等因素.

研究的目的:

调查传统中医药 (TCM) 在治疗刺激性肠综合征 (IBS) 中的疗效和安全性.
探索TCM在IBS中可能发挥作用的病理生理机制.
提供对TCM的见解,作为改善IBS症状管理和患者结果的补充方法.

主要方法:

关于IBS的TCM现有学术研究的文献综述.
分析研究,重点关注TCM对IBS病理生理学的影响.
关于TCM在临床实践中的安全性和有效性的证据综合.

主要成果:

传统中医 (TCM) 越来越多地被认可为其在IBS管理中的作用.
有证据表明,TCM可以解决与IBS有关的多种病理生理路径.
传统医学为IBS提供了一个潜在的有效和安全的补充治疗策略.

结论:

传统医疗证明了作为一种有价值的方法来管理刺激性肠综合征 (IBS) 的潜力.
了解TCM的机制可以导致IBS的向治疗.
需要进一步的研究,以充分阐明TCM在改善IBS患者护理和生活质量的作用.

关键词:

在IBS中,IBS是IBS.这是TCM,TCM.腹部疼痛腹部疼痛排泄障碍排泄障碍是一种排泄障碍.腹腹腹腹腹腹

更多相关视频

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation

Published on: July 5, 2024

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

Published on: October 13, 2023

相关概念视频

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...

Irritable Bowel Syndrome III: Medical and Nursing Management

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:

Drugs for Treatment of Constipation-Predominant IBS

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...

Drugs for Treatment of Diarrhea-Predominant IBS

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...